期刊文献+

程序、优选和决策:美国俄勒冈州药品报销目录制定方式 被引量:3

Procedure,Priority and Decision-making:Establishment Mechanism of Pharmaceutical Formulary List in Oregon,USA
下载PDF
导出
摘要 依照居民和社会对卫生服务的偏好,将药品和治疗方案按照不同的优先级别进行排序,从而决定进入目录内名单是俄勒冈州药品报销目录制定的主要特点。在报销目录制定程序中,采用电话访问以及召开社区会议和听证会的形式,积极采纳居民的意见,确保药品目录符合患者需求。当优选完成后,对药品报销目录政策按照一定的周期,进行重新审核和进一步调整,使其适应医学技术的发展与疾病谱的变化。 The state of Oregon in USA, in what has become known as the Oregon Plan, created what has been recognized as one of the most comprehensive approaches to an explicit rationing of heath care based on study of public rankings of the importance of different pharmaceuticals and health care procedures. In the process of formulary decision making, the Oregon laid out a solid ground work for new attempt at concentrating on what the residents really need by using the telephone survey, holding community meetings as well as public hearings. There is a requirement to keep the formulary under review in order to assure the health care procedures updated.
作者 李颖
出处 《医院院长论坛-首都医科大学学报(社会科学版)》 2009年第3期59-63,共5页 Hospital Directors‘ Forum
关键词 药品报销目录 决策优选 政策 Pharmaceutical Formulary List Priority Setting Policy
  • 相关文献

参考文献8

  • 1.
  • 2Julia Witt.How should we decide what to cover under medicare?[]..
  • 3.
  • 4J A Kitzhaber.Prioritizing health service in an ear of limits:the Oregon experience[].British Medical Journal l.993
  • 5Chris Ham.Retracing the Oregon trail:the experience of rationing and the Oregon health plan[].British Medical Journal.1998
  • 6Dixon J,Welch HG.Priority setting:Lessons from Oregon[].The Lancet.1991
  • 7Sen,Amartya K.Collective Choice and Social Welfare[]..1970
  • 8Arrow,K.J.Social Choice andIndividual Values[]..1963

同被引文献24

  • 1吴军.美国医疗保险体系对我们的启示[J].中国老年保健医学,2007,5(2):53-54. 被引量:1
  • 2郭三化,秦婷.试论国外医保模式对我国医保改革的借鉴意义[J].商业文化(学术版),2009,0(6):242-243. 被引量:2
  • 3高巍然,鱼敏,陈永鹏.浅谈《国家基本医疗保险药品目录》使用现状与改进建议[J].卫生软科学,2006,20(6):538-540. 被引量:2
  • 4Chalkidou K, Tunis S. Comparative effectiveness research and evidence-based health policy: experience from four countries[J]. Milbank Quarterly, 2009,87 (2) : 339.
  • 5Basskin L. Pharmaconomics and the formulary decisionmaking process[J]. Formulary, 1998,33 (2) : 456.
  • 6Kalipso C, Tom W, Anthony C, et al. Evidence informed decision making[J]. Health Service Research Policy, 2008,13:167.
  • 7王虎峰.药品和医疗技术评估制度亟待完善[EB/OL].http://www.jkb.com.cn/document.jsp?docid=137129&cat=01.2010-07-19.
  • 8傅鸿鹏.免费用药的国家选择[N].医药经济报,2014-06-09(F02).
  • 9Bhaumik S, Biswas T. Free medicine for all in India [ J ]. CMAJ, 2012, 184( 15): E783-784.
  • 10Sansom L. The subsidy of pharmaceuticals in Australia: processes and challenges[ J ]. Aus Health Rev, 2004, 28( 2 ): 194-205.

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部